In cell and gene therapy, every decision made during development has the...
Read More
Experimental Design: The Foundation of Successful Cell & Gene Therapy Development
Genomic Integrity Cell and Gene Therapy iPSC Therapy Starting Material Analysis
In cell and gene therapy, every decision made during development has the potential to impact patient safety, product quality, regulatory success, and ultimately, commercial viability. While tremendous attention is often placed on vector design, editing efficiency, and manufacturing processes, one critical component is sometimes overlooked: thoughtful experimental design.
Genomic Integrity: The Fourth Pillar of Quality in Cell and Gene Therapy
Cell and Gene Therapy
For decades, the biopharmaceutical industry has relied on three foundational quality attributes to evaluate therapeutic products:
For decades, the biopharmaceutical industry has relied on three foundational...
Read More
The Next Evolution of Cytogenetics: From Observation to Action
FDA Guidance Cell and Gene Therapy
For decades, cytogenetics has played a critical role in therapy development. It has helped us see when genomes are altered, unstable, or outright broken. But as cell and gene therapies become more sophisticated - and the margin for error shrinks - seeing is no longer enough.
For decades, cytogenetics has played a critical role in therapy development. It...
Read More
2025: A Pivotal Year for Genomic Insight - and What Comes Next in 2026
Allogeneic Cell Therapy Cell and Gene Therapy
Despite numerous challenges, the cell and gene therapy (CGT) sector has never moved faster. In 2025, we saw breakthroughs in precision editing, rapid scale-up of manufacturing platforms, and renewed investor attention on therapies with clear clinical differentiation. But alongside the scientific momentum, one theme stood out more than any other: genomic stability is now a defining hallmark for safety, reproducibility, and regulatory confidence.
Despite numerous challenges, the cell and gene therapy (CGT) sector has never...
Read More
Ensuring Genomic Integrity in Allogeneic Cell Therapy Development
Genomic Integrity CAR-NK Therapy Allogeneic Cell Therapy Cell and Gene Therapy iPSC Therapy CAR-T
Ensuring Genomic Integrity in Allogeneic Cell Therapy Development
Ensuring Genomic Integrity in Allogeneic Cell Therapy Development
Read More